Correlation Between Processa Pharmaceuticals and Histogen

Can any of the company-specific risk be diversified away by investing in both Processa Pharmaceuticals and Histogen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Processa Pharmaceuticals and Histogen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Processa Pharmaceuticals and Histogen, you can compare the effects of market volatilities on Processa Pharmaceuticals and Histogen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Processa Pharmaceuticals with a short position of Histogen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Processa Pharmaceuticals and Histogen.

Diversification Opportunities for Processa Pharmaceuticals and Histogen

0.69

Correlation Coefficient

Processa Pharmaceuticals  Histogen

Poor diversification

The 3 months correlation between Processa and Histogen is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Processa Pharmaceuticals and Histogen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Histogen and Processa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Processa Pharmaceuticals are associated (or correlated) with Histogen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Histogen has no effect on the direction of Processa Pharmaceuticals i.e., Processa Pharmaceuticals and Histogen go up and down completely randomly.

Pair Corralation between Processa Pharmaceuticals and Histogen

Given the investment horizon of 90 days Processa Pharmaceuticals is expected to under-perform the Histogen. But the stock apears to be less risky and, when comparing its historical volatility, Processa Pharmaceuticals is 1.31 times less risky than Histogen. The stock trades about -0.16 of its potential returns per unit of risk. The Histogen is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  2.00  in Histogen on December 1, 2024 and sell it today you would earn a total of  0.70  from holding Histogen or generate 35.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	65.0%
Values	Daily Returns

Processa Pharmaceuticals  vs.  Histogen

Processa Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Processa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Histogen

Risk-Adjusted Performance

OK

Over the last 90 days Histogen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very weak basic indicators, Histogen displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Processa Pharmaceuticals and Histogen

The main advantage of trading using opposite Processa Pharmaceuticals and Histogen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Processa Pharmaceuticals position performs unexpectedly, Histogen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will offset losses from the drop in Histogen's long position.

The idea behind Processa Pharmaceuticals and Histogen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.